-
241
Options of dyslipidemia treatment at non-alcoholic fatty liver disease
Published 2018-08-01“…Omega-3-PUFAs is one more option in the lipid metabolism disorders treatment in this group of patients. …”
Get full text
Article -
242
Prevalence of GCKR rs1260326 Variant in Subjects with Obesity Associated NAFLD and T2DM: A Case-Control Study in South Punjab, Pakistan
Published 2023-01-01“…The glucokinase regulatory protein (GCKR) regulates glycogen metabolism and insulin secretion, and the GCKR rs1260326 is a putative single nucleotide polymorphism (SNP) associated with metabolic disorders including nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM). …”
Get full text
Article -
243
PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia
Published 2015-01-01“…Irisin is related to insulin resistance and metabolic disorders. The physiologic effects of irisin are partially mediated through peroxisome proliferator-activated receptor-α (PPAR-α). …”
Get full text
Article -
244
Beneficial Effect of Fenofibrate in Combination with Silymarin on Parameters of Hereditary Hypertriglyceridemia-Induced Disorders in an Animal Model of Metabolic Syndrome
Published 2025-01-01“…<b>Conclusions:</b> Our results suggest the potential beneficial use of the combination of FF with SLM in the treatment of hypertriglyceridemia-induced metabolic disorders.…”
Get full text
Article -
245
Thalamic Lesions: A Radiological Review
Published 2014-01-01“…Thalamic lesions are seen in a multitude of disorders including vascular diseases, metabolic disorders, inflammatory diseases, trauma, tumours, and infections. …”
Get full text
Article -
246
Clinical Insight into Congenital Hypothyroidism Among Children
Published 2025-01-01“…Molecular, genetic, and technological advances have led to increased knowledge regarding neonatal thyroid hormone metabolism disorders. Maternal and fetal hypothyroidism, which can cause psychomotor dysfunction syndromes or low IQ levels, can lead to brain damage, reduced fetal growth and incidental fetal death. …”
Get full text
Article -
247
The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease
Published 2017-03-01“…Current studies are targeting new molecular mechanisms that underlie NAFLD and associated metabolic disorders. Many therapeutic targets have been found and used in clinical studies. …”
Get full text
Article -
248
Editorial: Weighing the impact of being overweight on female reproductive function and fertility
Published 2025-02-01Get full text
Article -
249
Roles of Chronic Low-Grade Inflammation in the Development of Ectopic Fat Deposition
Published 2014-01-01“…In this review, we have collected the evidence linking inflammation with ectopic fat deposition to get a better understanding of the underlying mechanism, which may provide us with novel therapeutic strategies for metabolic disorders.…”
Get full text
Article -
250
The Role of Human Gut Microbe Ruminococcus gnavus in Inflammatory Diseases
Published 2023-12-01“… Dysbiosis is a prominent factor in numerous inflammatory conditions, with Ruminococcus gnavus, a prevalent gut microbe, implicated in inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), eczema, metabolic disorders, and rheumatic diseases. R. gnavus contributes to inflammation by producing an inflammatory polysaccharide and degrading mucin. …”
Get full text
Article -
251
Clinical and genetic characteristics and medical approach in attenuated form of familial adenomatosis of the colon
Published 2011-05-01“…For this variant of adenomatosis absence of metabolic disorders and development of cancer after 50 years is typical that requires onset of treatment by endoscopic polypectomy with subsequent extensive resections of the colon if necessary.…”
Get full text
Article -
252
Placental Implications of Peroxisome Proliferator-Activated Receptors in Gestation and Parturition
Published 2008-01-01“…., chorioamnionitis), metabolic disorders (e.g., diabetes), and parturition.…”
Get full text
Article -
253
Impact of Incretin-Based Therapies on Adipokines and Adiponectin
Published 2021-01-01“…Adipokines are closely involved in most metabolic pathways and play an important modulatory role in lipid and carbohydrate homeostasis as they are involved in the pathophysiology of most metabolic disorders. Incretin-based therapy is a newly introduced class of antidiabetic drugs that restores euglycemia through several cellular processes; however, its effect on adipokines expression/secretion is not fully understood. …”
Get full text
Article -
254
Encapsulated human islets in alginate fiber maintain long-term functionality
Published 2024-03-01Get full text
Article -
255
-
256
Impaired RelA signaling and lipid metabolism dysregulation in hepatocytes: driving forces in the progression of metabolic dysfunction-associated steatotic liver disease
Published 2025-02-01“…This study explored the relationship between impaired RelA signaling and lipid metabolism disorders in hepatocytes, and how they synergistically contribute to the advancement of MASLD. …”
Get full text
Article -
257
Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus
Published 2017-01-01“…A change in microbial diversity, referred as microbial dysbiosis, alters the gut fermentation profile and intestinal wall integrity and causes metabolic endotoxemia, low-grade inflammation, autoimmunity, and other affiliated metabolic disorders. This article aims to summarize the role of the gut microbiome in the pathogenesis of diabetes. …”
Get full text
Article -
258
Peptide with Dual Roles in Immune and Metabolic Regulation: Liver-Expressed Antimicrobial Peptide-2 (LEAP-2)
Published 2025-01-01“…LEAP-2 alone or the LEAP-2/ghrelin molar ratio showed potential as therapeutic targets for obesity, diabetes, and metabolic disorders. This review explores the recent advances of LEAP-2 in immune modulation and energy regulation, highlighting its potential in treating the above diseases.…”
Get full text
Article -
259
Research Progress in Short-Chain Fatty Acid Modulation of the Gut-Bone Axis in Bone Metabolism
Published 2025-01-01“…As global aging intensifies, the incidence of age-related bone metabolic disorders, such as osteoporosis, continues to climb. …”
Get full text
Article -
260
Intricating connections: the role of ferroptosis in systemic lupus erythematosus
Published 2025-02-01“…Although ferroptosis, an iron-dependent form of cell death, has numerous pathophysiological features similar to those of SLE, such as intracellular iron accumulation, mitochondrial dysfunction, lipid metabolism disorders and concentration of damage associated-molecular patterns (DAMPs), only a few reports have demonstrated that ferroptosis is involved in SLE progression and that the role of ferroptosis in SLE pathogenesis continues to be neglected. …”
Get full text
Article